期刊文献+

盐酸坦索罗辛在防治混合痔术后急性尿潴留中的应用 被引量:10

下载PDF
导出
摘要 目的:探讨盐酸坦索罗辛在防治混合痔术后急性尿潴留中的应用。方法:我院收治混合痔患者568例,随机分成两组,盐酸坦索罗辛组260例,对照组308例,两组在性别、年龄上差异均无统计学意义,两组均在骶麻下行混合痔外剥内扎术。对照组按术前常规准备,盐酸坦索罗辛组术前2 d及术后3 d,每日服用盐酸坦索罗辛胶囊0.2 mg,2次/d。观察两组术后尿潴留发生情况及留置尿管3 d后拔除尿管的成功率。结果:盐酸坦索罗辛组术后尿潴留发生率为7.3%,对照组术后尿潴留发生率为19.8%,两组比较差异有统计学意义(x2=18.20,P<0.05)。留置尿管3 d后拔除尿管的成功率:盐酸坦索罗辛组为88.9%,对照组为52.5%,盐酸坦索罗辛组优于对照组(x2=4.83,P<0.05)。结论:围手术期服用盐酸坦索罗辛可以明显减少混合痔术后尿潴留的发生,同时可以提高早期拔除导尿管的成功率。
出处 《温州医学院学报》 CAS 2011年第3期277-278,共2页 Journal of Wenzhou Medical College
基金 温州市医药卫生科学研究基金资助项目(2010B024)
  • 相关文献

参考文献6

  • 1Janicke DM,Pundt MR.Anorectal disorders[J].Emerg Med Clin North Am,1996,14(4):757-788.
  • 2严建.痔瘘术后尿潴留的病因病机防治研究概况[J].湖南中医杂志,1999,15(4):51-51. 被引量:17
  • 3Kaplan SA,McCammon K,Fincher R,et al.Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency[J].J Urol,2009,182(6):2825-2830.
  • 4Naslund M J,Miner M.A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate[J].Clin Ther,2007,29(1):17-25.
  • 5Kawachi Y,Sakurai T,Sugimura S,et al.Long-term treatment and prognostic factors of alphal-blockers for lower urinary tract symptoms associated with benign prostatic hyperplasia:a pilot study comparing naftopidil and tamsulosin hydrochloride[J].Scand J Urol Nephrol,2010,44(1):38-45.
  • 6MeNeill SA,Daruwala PD,Mitchell ID,et al.Sustainedrelease alfazosin and trial without catheter after acute urinary retention:a prospective,placebo controlled trial[J].Br J Urol Int,1999,84(2):622-627.

二级参考文献8

共引文献16

同被引文献60

  • 1痔临床诊治指南(2006版)[J].中华胃肠外科杂志,2006,9(5):461-463. 被引量:2138
  • 2刘华波 林湘涛 王永杰.亚甲蓝用于肛肠病术后止痛的临床观察[J].中国肛肠病杂志,2000,20:41-41.
  • 3Duarte F M C, Costa W.Theincidence of postoperative respiratory depression in patients undergoing intravenous or epidural analgesia with opioids[J].Rev Bras Anestesiel, 2009, 59(4): 409-420.
  • 4Baldini G,Bagry H,Aprikian A,et al.Postoperative urinary retention:anesthetic and perioperative considerations[J].Anesthesiology,2009,110:1139-1157.
  • 5Buckley BS,Lapitan MC.Drugs for treatment of urinary retention after surgery in adults[J].Cochrane Database Syst Rev,2010,10:CD008023.
  • 6Darrah DM,Griebling TL,Silverstein JH.Postoperative urinary retention[J].Anesthesiol Clin,2009,27:465-484.
  • 7Petros JG,Rimm EB,Robillard RJ,et al.Factors influencing postoperative urinary retention in patients undergoing elective inguinal herniorrhaphy[J].Am J Surg,1991,161:431-434.
  • 8Gonüllü NN,Dülger M,Utkan NZ,etal.Prevention of postherniorrhaphy urinary retention with prazosin[J].Am Surg,1999,65:55-58.
  • 9Hindley RG,Brierly RD,Thomas PJ.Prostaglandin E2 and bethanechol in combination for treating detrusor underactivity[J].BJU Int,2004,93:89-92.
  • 10Jensen P,Mikkelsen T,Kehlet H.Postherniorrhaphy urinary retention-effect of local,regional,and general anesthesia:a review[J].Reg Anesth Pain Med.2002,27:612-617.

引证文献10

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部